Founded by Cancer Research UK (CRUK) and the National Cancer Institute (NIH-NCI, USA) the Cancer Grand Challenges are internationally funded…
featured news home
Results of a VHIO co-led retrospective study published in JCO Precision Oncology verify the use of diagnostic archival tissue biopsies…
The phase III international CheckMate 9ER trial continues to make headlines. Now published ahead of print in The Lancet Oncology…
The “J-BID – José Baselga Innovative Disruption Program” has an investment of up to 6 million euros and aims to…
Barcelona, June 10th, 2022. In an invited Comment article recently published online first in The Lancet Oncology (1) , co-authors Elena…
For the first time in the context of brain metastasis, VHIO-led research has evidenced the striking preclinical efficacy of a…
Treatment with trastuzumab deruxtecan, a combination of a targeted therapy with chemotherapy, increases progression-free survival of the disease and overall…
VHIO-led research published in Cancer Research Communications shows that the first-in-class MYC inhibitor Omomyc effectively halts disease progression in metastatic…
HER2DX is the world’s first diagnostic test formulated specifically for HER2-positive (HER2+) breast cancer. HER2DX analyzes RNA on 27 genes…
High-throughput RNA sequencing studies have led to the identification of several long noncoding RNAs (lncRNAs), but without apparent protein-coding roles….
